Kooij Louise Frederika: insider trades.
Kooij Louise Frederika reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($3.2M), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Kooij Louise Frederika
Companies
| Company | Relationship | Transactions |
|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | Officer · Chief Accounting Officer | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-20 | NewAmsterdam Pharma Co N.V. | S | 2,915 | $31.71 | 24,353 | Form 4 |
| 2026-07-20 | NewAmsterdam Pharma Co N.V. | S | 31,885 | $31.05 | 27,268 | Form 4 |
| 2026-07-20 | NewAmsterdam Pharma Co N.V. | S | 70,200 | $29.96 | 59,153 | Form 4 |
| 2026-07-20 | NewAmsterdam Pharma Co N.V. | M | 80,000 | $11.17 | 129,353 | Form 4 |
| 2026-07-20 | NewAmsterdam Pharma Co N.V. | M | 25,000 | $11.9 | 49,353 | Form 4 |
Questions
What stock did Kooij Louise Frederika buy or sell?
Kooij Louise Frederika reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($3.2M), across 1 company.
Is Kooij Louise Frederika the same person as other filers with this name?
This page covers SEC CIK 2004379 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/kooij-louise-frederika-2004379.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.